Skip to main content
Top
Published in: Journal of General Internal Medicine 15/2022

26-07-2022 | IgA Vasculitis | Clinical Image

IgA Vasculitis

Authors: Natalie Garcia, BS, Victoria Jiminez, BS, Alonso Heudebert, MD

Published in: Journal of General Internal Medicine | Issue 15/2022

Login to get access

Excerpt

A 37-year-old male presented with 2 weeks of abdominal pain, petechiae, palpable purpura, and arthralgias (Figs. 1 and 2). Past medical history was significant for hypertension, GERD, and family history of IBD. Initial rash began on the thighs and spread diffusely with significant burden on the nose, hands, and feet. Initial labs were notable for normal platelets, hematuria, and normal creatinine. An initial skin biopsy revealed leukocytoclastic vasculitis, and a secondary skin biopsy with immunofluorescence sent to Johns Hopkins revealed IgA immunoglobulins and C3 deposition in blood vessel walls, resulting in the definitive diagnosis of IgA vasculitis. Although IgA vasculitis notoriously affects the kidney blood vessel walls, a 24-h urine protein revealed minimal proteinuria. Treatment with prednisone improved symptom burden and led to full recovery.
Metadata
Title
IgA Vasculitis
Authors
Natalie Garcia, BS
Victoria Jiminez, BS
Alonso Heudebert, MD
Publication date
26-07-2022
Publisher
Springer International Publishing
Published in
Journal of General Internal Medicine / Issue 15/2022
Print ISSN: 0884-8734
Electronic ISSN: 1525-1497
DOI
https://doi.org/10.1007/s11606-022-07745-5

Other articles of this Issue 15/2022

Journal of General Internal Medicine 15/2022 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine